Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About John Tattory

John Tattory is recorded as CFO at Windtree Therapeutics Inc /De/ (WINT). Windtree Therapeutics Inc /De/ reported in an 8-K filed February 16, 2024 that John Tattory resigned as Interim Chief Financial Officer, effective February 15, 2024. Windtree Therapeutics Inc /De/ reported in an 8-K filed January 19, 2023 that John Tattory was appointed Interim Chief Financial Officer, effective January 27, 2023. Windtree Therapeutics Inc /De/ reported in an 8-K filed January 19, 2023 that John Tattory was appointed principal financial officer and principal accounting officer, effective January 27, 2023.

“On February 15, 2024, Windtree Therapeutics, Inc. (the “Company”) and John A. Tattory mutually agreed to Mr. Tattory’s resignation from his positions as the Interim Chief Financial Officer and principal financial officer of the Company, effective February 15, 2024.”
Windtree Therapeutics Inc /De/ Form 8-K, filed February 16, 2024 · Read the filing
“On January 18, 2023, the board of directors of the Company appointed John Tattory as Interim Chief Financial Officer, effective as of the Effective Date.”
Windtree Therapeutics Inc /De/ Form 8-K, filed January 19, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Windtree Therapeutics Inc /De/

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.